Physician-owned ASCs drive growth in global osteosynthesis devices market: 4 key notes

Technavio, a global technology research and advisory company, expects emerging physician-owned ASCs will drive the global osteosynthesis devices market from 2016 to 2026, among other trends.

Advertisement

Here are four key notes:

1. Surgeons are increasingly performing arthroscopy procedures on an outpatient basis, fueling the demand for physicians owning surgery centers.

2. More minimally invasive surgeries in unsaturated markets will boost the number of physician-owned ASCs.

3. As surgeons perform more highly advanced MIS procedures, the demand for osteosynthesis devices will follow suit.

4. Other market drivers include the augmented fixation of orthopedic implants with stem cells, demand for bioresorbable devices and growth in personalized osteosynthesis products.

More healthcare news:
Anthem is 1st payer to challenge DOJ lawsuit: 5 takeaways
Boston University to increase dermatologists practicing in academia: 5 takeaways from the new residency program
40% of residents rake in $200k+ of medical school debt — 12 statistics on resident debt

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in ASC News

Advertisement

Comments are closed.